Details of the procedures divided upon aortic repair both as endovascular aortic repair for infrarenal abdominal aorta (EVAR) and thoracic endovascular aortic repair (TEVAR)
| . | Overall-44, N (%) . | EVAR-36, N (%) . | TEVAR-8, N (%) . |
|---|---|---|---|
| Preoperative factors | |||
| Male | 30 (68) | 25 (69) | 5 (62) |
| Urgent aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Hostile bilateral femoral/iliac access | 11 (25) | 10 (27) | 1 (12) |
| Iliac aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Simultaneous group | 25 (57) | 22 (61) | 3 (37) |
| Staged group | 19 (43) | 14 (39) | 5 (62) |
| Days between procedures (Staged group) | 72 (IQR: 57–87) | – | 74 (IQR: 58–89) |
| Intraoperative details | |||
| General anaesthesia TEVAR/EVAR | 23 (52) | 15 (42) | 8 (100) |
| Percutaneous femoral access TEVAR/EVAR | 27 (61) | 24 (67) | 3 (37) |
| Percutaneous femoral access TAVI | 30 (68) | 26 (72) | 4 (60) |
| Need for iliac adjunctive procedures | 4 (9) | 4 (11) | 0 (0) |
| Technical success | 44 (100) | 36 (100) | 8 (100) |
| Postoperative results | |||
| Cardiac adverse events | 2 (5) | 1 (3) | 1 (12) |
| Cerebrovascular adverse events | 2 (5) | 1 (3) | 1 (12) |
| Respiratory adverse events | 5 (11) | 2 (6) | 3 (37) |
| Reinterventions | 1 (2) | 1 (3) | 0 (0) |
| Vascular access complication | 2 (5) | 2 (6) | 0 (0) |
| Death | 1 (2) | 0 (0) | 1 (12) |
| . | Overall-44, N (%) . | EVAR-36, N (%) . | TEVAR-8, N (%) . |
|---|---|---|---|
| Preoperative factors | |||
| Male | 30 (68) | 25 (69) | 5 (62) |
| Urgent aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Hostile bilateral femoral/iliac access | 11 (25) | 10 (27) | 1 (12) |
| Iliac aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Simultaneous group | 25 (57) | 22 (61) | 3 (37) |
| Staged group | 19 (43) | 14 (39) | 5 (62) |
| Days between procedures (Staged group) | 72 (IQR: 57–87) | – | 74 (IQR: 58–89) |
| Intraoperative details | |||
| General anaesthesia TEVAR/EVAR | 23 (52) | 15 (42) | 8 (100) |
| Percutaneous femoral access TEVAR/EVAR | 27 (61) | 24 (67) | 3 (37) |
| Percutaneous femoral access TAVI | 30 (68) | 26 (72) | 4 (60) |
| Need for iliac adjunctive procedures | 4 (9) | 4 (11) | 0 (0) |
| Technical success | 44 (100) | 36 (100) | 8 (100) |
| Postoperative results | |||
| Cardiac adverse events | 2 (5) | 1 (3) | 1 (12) |
| Cerebrovascular adverse events | 2 (5) | 1 (3) | 1 (12) |
| Respiratory adverse events | 5 (11) | 2 (6) | 3 (37) |
| Reinterventions | 1 (2) | 1 (3) | 0 (0) |
| Vascular access complication | 2 (5) | 2 (6) | 0 (0) |
| Death | 1 (2) | 0 (0) | 1 (12) |
IQR: interquartile range.
Details of the procedures divided upon aortic repair both as endovascular aortic repair for infrarenal abdominal aorta (EVAR) and thoracic endovascular aortic repair (TEVAR)
| . | Overall-44, N (%) . | EVAR-36, N (%) . | TEVAR-8, N (%) . |
|---|---|---|---|
| Preoperative factors | |||
| Male | 30 (68) | 25 (69) | 5 (62) |
| Urgent aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Hostile bilateral femoral/iliac access | 11 (25) | 10 (27) | 1 (12) |
| Iliac aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Simultaneous group | 25 (57) | 22 (61) | 3 (37) |
| Staged group | 19 (43) | 14 (39) | 5 (62) |
| Days between procedures (Staged group) | 72 (IQR: 57–87) | – | 74 (IQR: 58–89) |
| Intraoperative details | |||
| General anaesthesia TEVAR/EVAR | 23 (52) | 15 (42) | 8 (100) |
| Percutaneous femoral access TEVAR/EVAR | 27 (61) | 24 (67) | 3 (37) |
| Percutaneous femoral access TAVI | 30 (68) | 26 (72) | 4 (60) |
| Need for iliac adjunctive procedures | 4 (9) | 4 (11) | 0 (0) |
| Technical success | 44 (100) | 36 (100) | 8 (100) |
| Postoperative results | |||
| Cardiac adverse events | 2 (5) | 1 (3) | 1 (12) |
| Cerebrovascular adverse events | 2 (5) | 1 (3) | 1 (12) |
| Respiratory adverse events | 5 (11) | 2 (6) | 3 (37) |
| Reinterventions | 1 (2) | 1 (3) | 0 (0) |
| Vascular access complication | 2 (5) | 2 (6) | 0 (0) |
| Death | 1 (2) | 0 (0) | 1 (12) |
| . | Overall-44, N (%) . | EVAR-36, N (%) . | TEVAR-8, N (%) . |
|---|---|---|---|
| Preoperative factors | |||
| Male | 30 (68) | 25 (69) | 5 (62) |
| Urgent aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Hostile bilateral femoral/iliac access | 11 (25) | 10 (27) | 1 (12) |
| Iliac aneurysm | 3 (7) | 3 (8) | 0 (0) |
| Simultaneous group | 25 (57) | 22 (61) | 3 (37) |
| Staged group | 19 (43) | 14 (39) | 5 (62) |
| Days between procedures (Staged group) | 72 (IQR: 57–87) | – | 74 (IQR: 58–89) |
| Intraoperative details | |||
| General anaesthesia TEVAR/EVAR | 23 (52) | 15 (42) | 8 (100) |
| Percutaneous femoral access TEVAR/EVAR | 27 (61) | 24 (67) | 3 (37) |
| Percutaneous femoral access TAVI | 30 (68) | 26 (72) | 4 (60) |
| Need for iliac adjunctive procedures | 4 (9) | 4 (11) | 0 (0) |
| Technical success | 44 (100) | 36 (100) | 8 (100) |
| Postoperative results | |||
| Cardiac adverse events | 2 (5) | 1 (3) | 1 (12) |
| Cerebrovascular adverse events | 2 (5) | 1 (3) | 1 (12) |
| Respiratory adverse events | 5 (11) | 2 (6) | 3 (37) |
| Reinterventions | 1 (2) | 1 (3) | 0 (0) |
| Vascular access complication | 2 (5) | 2 (6) | 0 (0) |
| Death | 1 (2) | 0 (0) | 1 (12) |
IQR: interquartile range.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
